Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats
Surfactant therapy is a standard of care for preterm infants with respiratory distress and reduces the incidence of death and bronchopulmonary dysplasia in these patients. Our previous study found that mesench...
Source: Stem Cell Research and Therapy - Category: Stem Cells Authors: Hsiu-Chu Chou, Chien-Hsiang Chang, Chien-Han Chen, Willie Lin and Chung-Ming Chen Tags: Research Source Type: research
More News: Bronchopulmonary Dysplasia | Perinatology & Neonatology | Respiratory Medicine | Stem Cell Therapy | Stem Cells | Study